Our comprehensive kidney treatment program covers a wide variety of innovative therapies. These include dialysis options that are tailored to patient needs, one of the nation’s largest and most successful kidney transplantation programs and leading-edge advancement of care standards for kidney-related issues, including kidney stones.

With a focus on basic, translational and clinical research as well as the consequences of kidney problems, our Division of Nephrology tests new pharmaceutical agents, identifies novel and more effective applications for existing drugs and researches biomarkers for immunologic diseases that affect the kidneys, such as systemic lupus erythematosus (SLE).

We are also committed to educating the next generation of nephrologists through our highly respected Fellowship Program in Kidney Diseases.

In addition to treatments and clinics for hypertension and genetic forms of kidney disease, our comprehensive kidney stone management program focuses on the latest surgical and non-surgical procedures that can prevent, treat and manage even the most challenging cases.

By providing more effective and rapid diagnoses and treatment, we are working toward reducing the burden of kidney disease worldwide.

Nephrology Leadership

Our leaders

Rovin Brad Nephrology

Brad Rovin, MD

Director, Division of Nephrology

Brad Rovin, MD, is the director of the Division of Nephrology at The Ohio State Wexner Medical Center. Dr. Rovin specializes in autoimmune kidney diseases and how the immune system interacts with the kidney and causes renal inflammation and injury.

Share this Page